Back to list

LIPOSORBER LA-15 system for Adult and Pediatric FSGS

University of North Carolina at Chapel Hill


Description

To evaluate the safety and efficacy of a device removing lipids from the blood using an apheresis device in treating primary FSGS


Keywords:

Kidneys


Category:

Device

Qualifications

 


Age
0 - 75 years


Gender
Any


Study Population

Patients with primary Focal segmental glomerulosclerosis (FSGS) before or after transplant


Investigator

Koyal Jain
Clinical Assistant Professor
Medicine-Nephrology

For questions, contact:

Anne Froment
anne_froment@med.unc.edu
(919) 445-2622


Recruitment Period End

December 30, 2022

Location

Primary Location
CTRC
Burnett-Womack Building, 160 Dental Cir, Chapel Hill, NC 27514, USA
Secondary Location
UNC Hospitals
101 Manning Dr, Chapel Hill, NC 27514, USA

Study Qualifications

Gender Any

Age Range 0 - 75 years

Participant qualification(s) -not responding to standard treatments -good kidney function (eGFR>=60) or post-transplant -No cardiac problems

Not eligible if: -pregnant or lactating -low kidney function (eGFR < 60) -body weight < 18 kg (39.7 lbs)

Number of Visits

    » 18 In person visit(s)

    1 baseline, 12 treatments, 5 follow-up visits

    » 0 Remote visit(s)

Participation Period

24 months

Compensation

$50 per visit

By clicking I am interested, your contact information will be sent to the researcher/study coordinator for this study. The coordinator will respond by email with additional information on how to proceed.